AFP and neoplasm: The response to LRT treatment, measured by the decrease in tumor burden with a concomitant decline of AFP levels or its low initial concentration, is a surrogate of less aggressive tumor biology, which thus yields a good long-term prognosis after liver transplantation, with 5-year survival rates reaching 70% [23].